Pravastatin Treatment of Very Low Density, Intermediate Density and Low Density Lipoproteins in Hypercholesterolemia and Combined Hyperlipidemia Secondary to the Nephrotic Syndrome

Publisher： Karger

E-ISSN： 1421-9670|20|1|12-17

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.20, Iss.1, 2000-01, pp. : 12-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney Disease

By  

Cardiorenal Medicine, Vol. 2, Iss. 1, 2012-01 ,pp. : 57-65

Karger

Access to resources Recommend Favorite

Effects of Pravastatin on Superoxide and Fibronectin Production of Mesangial Cells Induced by Low-Density Lipoprotein

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 1, 2002-02 ,pp. : 2-6

Karger

Access to resources Recommend Favorite

Effect of Low-Density Lipoprotein Apheresis on Circulating Endothelial Progenitor Cells in Familial Hypercholesterolemia

By  

Blood Purification, Vol. 29, Iss. 4, 2010-05 ,pp. : 383-389

Karger

Access to resources Recommend Favorite

Native and Oxidized Low–Density Lipoproteins Enhance Superoxide Production from Diabetic Rat Glomeruli

By  

Kidney and Blood Pressure Research, Vol. 23, Iss. 2, 2000-03 ,pp. : 133-137

Karger

Access to resources Recommend Favorite

Evolution Pattern of Auto-Antibodies against Oxidized Low-Density Lipoproteins in Renal Transplant Recipients

By  

Nephron, Vol. 89, Iss. 3, 2001-10 ,pp. : 303-308

Karger

Access to resources Recommend Favorite